CGTLive’s Weekly Rewind – August 25, 2023

News
Article

Review top news and interview highlights from the week ending August 25, 2023.

Welcome to CGTLive™’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.

1. CAR-M/Pembrolizumab Trial Doses First Patient With HER2-Overexpressing Solid Tumors

Initial data from the combination substudy are expected in the second half of 2023.

2. Robert J. Hariri, MD, PhD, on the Importance of Placental-Derived Stem Cells in Cell Therapy

The founder, chairman, and CEO of Celularity discussed the advantages of cells derived from umbilical cord blood versus other sources of cells for cell therapies.

3. Gene Therapy Improves Grade 2/3 Xerostomia Symptoms

Participants treated both unilaterally or bilaterally reported clinically meaningful improvements on GRCQ and XQ scale scores.

4. Thomas Povsic, MD, PhD, on Addressing Unmet Needs in Refractory Angina With Gene Therapy

The interventional cardiologist and professor, Duke University School of Medicine, discussed how XC001 could improve outcomes for patients with refractory angina.

5. Gaucher Disease Type 1 Gene Therapy Trial Proceeds to Dose Second Cohort

The company announced that it had completed dosing in the first cohort of the GALILEO-1 trial of FLT201.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Recent Videos
Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine
Surbhi Sidana, MD, an assistant professor of medicine, bone marrow transplantation, and cellular therapy at Stanford
Alexey Danilov, MD, PhD, the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, codirector of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California
© 2025 MJH Life Sciences

All rights reserved.